Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA277687 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR1852860_1.fastq.gz | Fastqsanger.gz | |||
| SRR1852860_2.fastq.gz | Fastqsanger.gz | |||
| SRR1852861_1.fastq.gz | Fastqsanger.gz | |||
| SRR1852861_2.fastq.gz | Fastqsanger.gz | |||
| SRR1852881_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 10 |
Similar Datasets
Project description:Transcription profiling by array of human CD4+ T cells from HIV-resistant and HIV-susceptible individuals
2025-01-24 | E-GEOD-14278 | ExpressionAtlas
Project description:RNA-seq of coding RNA in primary human hematopoietic cells treated with UNC0638 or DMSO control
2025-01-24 | E-GEOD-71421 | ExpressionAtlas
Project description:RNA-seq of SARS-CoV-2-infected human primary hepatocyte-derived spheroids upon interferon a2 and baricitinib treatment
2025-01-23 | E-MTAB-9711 | ExpressionAtlas
Project description:Transcription profiling by array of human CD4+ T-lymphocytes infected with VSVG-pseudotyped HIV-1 viruses lacking Env, Vpr, and Nef
2025-01-24 | E-GEOD-12963 | ExpressionAtlas
Project description:RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits
2025-01-24 | E-GEOD-59089 | ExpressionAtlas
Project description:Transciptiome of human primary resting CD4 T lymphocytes infected with HIV-1
| PRJNA355967 | ENA
Project description:Transcription profiling by array of human CD4+T-cells, Th1/Th2 polarized time-series and primary memory subsets
2025-01-23 | E-MTAB-4687 | ExpressionAtlas
Project description:CD8+ and CD4+ T cells from HIV infected patients with HIV-RNA viremia
| PRJNA134707 | ENA
Project description:Transcription profiling by array of human CD4 positive T cells treated with lipoprotein-bound HIV-1 gp120 V3 domain peptide
2025-01-22 | E-MEXP-1586 | ExpressionAtlas
Project description:Host directed therapies against HIV-1 are thought to be critical for long term containment of the HIV-1 pandemic but remain elusive. Since HIV-1 infects and manipulates important effectors of both the innate and adaptive immune system, identifying modulations of the host cell systems in humans during HIV-1 infection may be crucial for the development of immune based therapies. Here, we quantified the changes of the proteome in human CD4+ T cells upon HIV-1 infection, both in vitro and in vivo. A SWATH-MS approach was used to measure the proteome of human primary CD4+ T cells infected with HIV-1 in vitro as well as CD4+ T cells from HIV-1 infected patients with paired samples on and off antiretroviral treatment. In the in vitro experiment, the proteome of CD4+ T cells was quantified over a time course following HIV-1 infection. 1,725 host cell proteins and 4 HIV-1 proteins were quantified, with 145 proteins changing significantly during the time course. Changes in the proteome peaked 24 hours after infection, concomitantly with significant HIV-1 protein production. In the in vivo branch of the study, CD4+ T cells from viremic patients and those with no detectable viral load after treatment were sorted and the proteomes quantified. We consistently detected 895 proteins, 172 of which were considered to be significantly different between viraemic patients and patients undergoing successful treatment. The proteome of in vitro infected CD4+ T cells was modulated on multiple functional levels, including TLR-4 signalling and the type 1 interferon signalling pathway. Perturbations in the type 1 interferon signalling pathway were recapitulated in CD4+ T cells from patients. The study shows that proteome maps generated by SWATH-MS indicate a range of functionally significant changes in the proteome of HIV infected human CD4+ T cells. Exploring these perturbations in more detail may help identify new targets for immune based interventions.
2017-02-28 | PXD005234 | Pride